Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a222f8233d695e37

Jump to content

// Workers AI · dad joke modeWhy did NOVA1 go to therapy? It had explosive issues.

From Wikipedia, the free encyclopedia
NOVA1
Identifiers
AliasesNOVA1, Nova-1, NOVA alternative splicing regulator 1
External IDsOMIM: 602157; MGI: 104297; HomoloGene: 21296; GeneCards: NOVA1; OMA:NOVA1 - orthologs
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002515
NM_006489
NM_006491

RefSeq (protein)
Location (UCSC)Chr 14: 26.44 – 26.6 MbChr 12: 46.69 – 46.82 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

RNA-binding protein Nova-1 is a protein that in humans is encoded by the NOVA1 gene.[5][6]

This gene encodes a neuron-specific RNA-binding protein, a member of the Nova family of paraneoplastic disease antigens, that is recognized and inhibited by paraneoplastic antibodies. These antibodies are found in the sera of patients with paraneoplastic opsoclonus-ataxia, breast cancer, and small cell lung cancer. Alternatively spliced transcripts encoding distinct isoforms have been described.[6] Both Neanderthals and Denisovans had one version and nearly all modern humans had another suggesting positive selection. Insertion of Neanderthal gene variant of the neuro-oncological ventral antigen 1 (NOVA1) gene into human cortical organoids might promote slower development and higher surface complexity in the brain models,[7] but this may be an artefact of a CRISPR side effect,[8][9] as it could not be replicated in a subsequent study.[10]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000139910 Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000021047 Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Buckanovich RJ, Yang YY, Darnell RB (Feb 1996). "The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies". J Neurosci. 16 (3): 1114–22. doi:10.1523/JNEUROSCI.16-03-01114.1996. PMC 6578795. PMID 8558240.
  6. 1 2 "Entrez Gene: NOVA1 neuro-oncological ventral antigen 1".
  7. "Neanderthal Gene Variant Alters Neurodevelopment in Human Brain Organoids". 11 February 2021.
  8. Maricic T, Helmbrecht N, Riesenberg S, Macak D, Kanis P, Lackner M, Pugach-Matveeva AD, Pääbo S (2021-10-15). "Comment on "Reintroduction of the archaic variant of NOVA1 in cortical organoids alters neurodevelopment"". Science. 374 (6565) eabi6060. doi:10.1126/science.abi6060. ISSN 0036-8075. PMID 34648345. S2CID 238990790.
  9. Herai RH, Szeto RA, Trujillo CA, Muotri AR (2021-10-15). "Response to Comment on "Reintroduction of the archaic variant of NOVA1 in cortical organoids alters neurodevelopment"". Science. 374 (6565) eabi9881. doi:10.1126/science.abi9881. ISSN 0036-8075. PMID 34648331. S2CID 238990560.
  10. Riesenberg S, Kanis P, Macak D, Wollny D, Düsterhöft D, Kowalewski J, Helmbrecht N, Maricic T, Pääbo S (2023-07-20). "Efficient high-precision homology-directed repair-dependent genome editing by HDRobust". Nature Methods. 20 (9): 1388–1399. doi:10.1038/s41592-023-01949-1. ISSN 1548-7091. PMC 10482697. PMID 37474806.

Further reading

[edit]